---
title: Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation
nct_id: NCT03108430
overall_status: UNKNOWN
sponsor: Centre Hospitalier Universitaire, Amiens
study_type: OBSERVATIONAL
primary_condition: Inhalation Pneumonia
countries: France
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03108430.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03108430"
ct_last_update_post_date: 2017-04-11
last_seen_at: "2026-05-12T06:31:19.185Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation

**NCT ID:** [NCT03108430](https://clinicaltrials.gov/study/NCT03108430)

## Key Facts

- **Status:** UNKNOWN
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 60
- **Lead Sponsor:** Centre Hospitalier Universitaire, Amiens
- **Conditions:** Inhalation Pneumonia, Risk Factor
- **Start Date:** 2016-08-22
- **Completion Date:** 2017-08-21
- **CT.gov Last Update:** 2017-04-11

## Brief Summary

Inhalation pneumonia (PI) is common in clinical practice but is rarely studied. For example, there are no data on the incidence of pneumonia after inhalation and risk factors or protective factors to develop one since it is known that anyone who inhaled does not necessarily develop an IP. There is no data on the benefit of treating inhalation by antibiotic therapy pre-emptively although this practice is common. In this context, this observational study wishes to take stock of the situation on the subject in order to determine what actions to implement to prevent IP.

## Eligibility

- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* In intensive care: Any intubated patient who presented:
* It is a coma with GCS ≤ 12 without VAS protection, whatever the duration
* Either a proven inhalation, defined by the presence in the VAS of gastric fluid or food
* Either a suspected inhalation, defined by the extrahospital anamnesis
* In medicine :
* Any wrong way (defined by a reflex cough when taking food)
* Coma without intubation, regardless of duration or depth

Exclusion Criteria:

* Patients with VAP
```

## Arms

- **Inhalation pneumonia**
- **Proven inhalations**
- **Suspected inhalations (coma + anamnesis)**

## Interventions

- **Risk factors and incidence of IP after inhalation** (OTHER) — Calculate the annual incidence of PI, the incidence of PI in inhaled patients (in each subgroup), and analyze the risk factors by logistic regression, based on the number of patients hospitalized during the study period.

## Primary Outcomes

- **Calculate the annual incidence of PI, the incidence of PI in inhaled patients (in each subgroup), and analyze the risk factors by logistic regression, based on the number of patients hospitalized during the study period.** _(time frame: 1 day)_

## Locations (1)

- CHU Amiens Picardie, Amiens, Picardie, France — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.chu amiens picardie|amiens|picardie|france` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03108430.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03108430*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*